{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:28:44Z","timestamp":1761128924985},"reference-count":12,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.lpm.2011.06.006","type":"journal-article","created":{"date-parts":[[2011,7,27]],"date-time":"2011-07-27T23:04:08Z","timestamp":1311807848000},"page":"828-829","source":"Crossref","is-referenced-by-count":1,"special_numbering":"P1","title":["Actualit\u00e9s des arthropathies microcristallines"],"prefix":"10.1016","volume":"40","author":[{"given":"Pascal","family":"Richette","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2011.06.006_bib0005","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0140-6736(09)60883-7","article-title":"Gout","volume":"375","author":"Richette","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2011.06.006_bib0010","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/BOR.0b013e32833645e8","article-title":"Genetics of gout","volume":"22","author":"Choi","year":"2010","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.lpm.2011.06.006_bib0015","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/ar3199","article-title":"Epidemiology of gout","volume":"12","author":"Roddy","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.lpm.2011.06.006_bib0020","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3\u00a0inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.lpm.2011.06.006_bib0025","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1002\/art.27600","article-title":"Canakinumab for the treatment of acute flares in difficult-to-treat gouty arthritis: results of a multicenter, phase II, dose-ranging study","volume":"62","author":"So","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2011.06.006_bib0030","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1136\/ard.2009.108936","article-title":"The interleukin 1\u00a0inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study","volume":"68","author":"Terkeltaub","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2011.06.006_bib0035","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0140-6736(10)60665-4","article-title":"Gout therapeutics: new drugs for an old disease","volume":"377","author":"Burns","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2011.06.006_bib0040","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1056\/NEJMoa050373","article-title":"Febuxostat compared with allopurinol in patients with hyperuricemia and gout","volume":"353","author":"Becker","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2011.06.006_bib0045","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/rheumatology\/kep081","article-title":"An update on the epidemiology of calcium pyrophosphate dihydrate crystal deposition disease","volume":"48","author":"Richette","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.lpm.2011.06.006_bib0050","doi-asserted-by":"crossref","unstructured":"Zhang W, Doherty M, Bardin T, Barskova V, Guerne PA, Jansen TL, et al. European league against rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis. Ann Rheum Dis 2011.","DOI":"10.1136\/ard.2010.139105"},{"key":"10.1016\/j.lpm.2011.06.006_bib0055","doi-asserted-by":"crossref","unstructured":"Zhang W, Doherty M, Pascual E, Barskova V, Guerne PA, Jansen TL, et al. European league against rheumatism recommendations for calcium pyrophosphate deposition. Part II: Management. Ann Rheum Dis 2011.","DOI":"10.1136\/ard.2010.139105"},{"key":"10.1016\/j.lpm.2011.06.006_bib0060","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.4049\/jimmunol.1001284","article-title":"Basic calcium phosphate crystals induce monocyte\/macrophage IL-1beta secretion through the NLRP3\u00a0inflammasome in vitro","volume":"186","author":"Pazar","year":"2011","journal-title":"J Immunol"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498211003460?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498211003460?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T09:43:43Z","timestamp":1560419023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498211003460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":12,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0755498211003460"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2011.06.006","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}